-
Federal
Behavioral Health Services Provided to the Medicaid and CHIP Population
U.S. Department of Health & Human Services —
This data set includes monthly counts and rates (per 1,000 beneficiaries) of behavioral health services, including emergency department services, inpatient services,... -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 09-01-2025-to-09-07-2025
U.S. Department of Health & Human Services —
The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the... -
Federal
Separate CHIP Enrollment by Month and State – Historic CAA/Unwinding Period
U.S. Department of Health & Human Services —
This historic dataset with total enrollment in separate CHIP programs by month and state was created to fulfill reporting requirements under section 1902(tt)(1) of... -
Federal
HealthCare.gov Transitions Marketplace Medicaid Unwinding Report
U.S. Department of Health & Human Services —
Metrics from individual Marketplaces during the current reporting period. The report includes data for the states using HealthCare.gov. Sources: HealthCare.gov... -
Federal
Respiratory Conditions in the Medicaid and CHIP Population
U.S. Department of Health & Human Services —
This data set includes monthly counts and percentages of Medicaid and CHIP beneficiaries, by state, who received at least one service for each of the following... -
Federal
Medicaid Financial Management Data – National Totals
U.S. Department of Health & Human Services —
This dataset reports summary state-by-state total expenditures by program for the Medicaid Program, Medicaid Administration and CHIP programs. These state... -
Federal
Medicaid and CHIP CAA Reporting Metrics
U.S. Department of Health & Human Services —
State-reported data on Medicaid and CHIP eligibility renewals conducted during the reporting period and call center operations Sources: (1) March and April 2023 state... -
Federal
MLR Summary Reports
U.S. Department of Health & Human Services —
The MLR Summary Reports provide plan-specific MLRs for Medicaid managed care programs. The MLR summary report data include MLRs for MCOs, PIHPs, and PAHPs submitted... -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 06/1/2025)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Medicaid CMS-64 CAA 2023 Increased FMAP Expenditure Data Collected through MBES/CBES
U.S. Department of Health & Human Services —
Notes: 1. CAA 2023 provides a temporary 5.0 percentage point FMAP increase to each qualifying state and territory's FMAP under section 1905(b) of the Act, beginning... -
Federal
State-based Marketplace (SBM) Medicaid Unwinding Report
U.S. Department of Health & Human Services —
Metrics from individual Marketplaces during the current reporting period. The report includes data for the states using State-based Marketplaces (SBMs) that use their... -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2023-08-07-to-2023-08-13
U.S. Department of Health & Human Services —
The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the... -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2023-08-28-to-2023-09-03
U.S. Department of Health & Human Services —
The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the... -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2023-05-01-to-2023-05-07
U.S. Department of Health & Human Services —
The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the... -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2024-01-01-to-2024-01-07
U.S. Department of Health & Human Services —
The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the... -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2022-03-07 to 2022-03-13
U.S. Department of Health & Human Services —
The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the... -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2024-01-29-to-2024-02-04
U.S. Department of Health & Human Services —
The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the... -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2023-07-10-to-2023-07-16
U.S. Department of Health & Human Services —
The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the...